Predicting Changes in Cardiovascular Risk Factors in Type 2 Diabetes in the Post-UKPDS Era: Longitudinal Analysis of the Swedish National Diabetes Register

Table 1

Total and validation samples characteristics in the year of diagnosis of diabetes.

Variable	Total sample	Validation sample	No difference
	(𝑛=5043)	(𝑛=414)	𝑃 value
	Mean (±SD)	Mean (±SD)
	(1)^a	(2)	(3)
Male (𝑛)	2967	244
Age at diagnosis	56.0 (8.8)	57.0 (8.0)	0.11
HbA1c (%)	7.0 (1.4)	6.8 (1.2)	0.02
BMI (Kg/m^2)	29.8 (4.9)	29.8 (4.7)	0.87
Systolic BP (mmHg)	138.5 (17.9)	135.9 (16.6)	0.03
TC : HDL^b	4.6 (1.4)	4.5 (1.2)	0.12
LDL cholesterol (mmolL^−1)^b	3.1 (1.0)	3.1 (1.0)	0.98
Smokers (proportion, %)	21.0	14.0	<0.01
Female (𝑛)	2076	170
Age at diagnosis	57.0 (9.0)	59.0 (7.0)	<0.01
HbA1c (%)	6.9 (1.3)	6.8 (1.1)	0.07
BMI (Kg/m^2)	30.7 (5.9)	30.4 (5.7)	0.42
Systolic BP (mmHg)	138.9 (18.2)	138.8 (15.6)	0.97
TC : HDL	4.4 (1.4)	4.2 (1.4)	0.19
LDL cholesterol (mmolL^−1)	3.3 (1.0)	3.2 (1.0)	0.75
Smokers (proportion, %)	22.0	18.0	0.23

^aThe 𝑃 values based on ANOVA analysis showed that there were no statistically significant differences in the means of risk factors between total sample and estimation subsamples for time paths of risk factors. ^bAs data on lipid levels were collected since 2002, these figures are based on data for 3214 patients.